Search

everythinglearnresearchcommunity

for

Search:↓

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

BMS-470539 reduces skin fibrosis and inflammation.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Thymosin β4 helps with healing, inflammation, and organ protection.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The study developed a successful mouse model to study skin infections, highlighting the importance of choosing the right fungal strains.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

α-Mangostin can naturally lighten skin by reducing melanin.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Posaconazole is a promising new treatment for toenail fungus.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.